Jiny Kim - 08 Aug 2025 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Director
Signature
/s/ Peter J. Mariani attorney-in-fact Jiny Kim
Issuer symbol
CTSO
Transactions as of
08 Aug 2025
Net transactions value
$0
Form type
4
Filing time
08 Aug 2025, 19:36:38 UTC
Previous filing
04 Apr 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kim Jiny Director C/O CYTOSORBENTS CORPORATION, 305 COLLEGE ROAD EAST, PRINCETON /s/ Peter J. Mariani attorney-in-fact Jiny Kim 08 Aug 2025 0001920967

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTSO Common Stock 77,819 08 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTSO Stock Option (Right to Buy) Award $0 +22,000 $0.000000 22,000 08 Aug 2025 Common Stock 22,000 $1.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (a) 69,300 restricted stock units ("RSUs") granted on April 1, 2022 that will be settled into shares of Common Stock upon vesting upon a "Change In Control" of the Company as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan") and (b) 8,519 shares of Common Stock owned by the reporting person.
F2 The stock options were granted pursuant to the Plan. The shares underlying the stock options will vest in four (4) equal quarterly installments over a period of one year following the date of grant, subject to the reporting person's continued service as of the applicable vesting date.

Remarks:

Exhibit 24.1 Power of Attorney